208 related articles for article (PubMed ID: 25913715)
1. Primary mediastinal large B-cell lymphoma.
Bhatt VR; Mourya R; Shrestha R; Armitage JO
Cancer Treat Rev; 2015 Jun; 41(6):476-85. PubMed ID: 25913715
[TBL] [Abstract][Full Text] [Related]
2. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
3. Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach.
Hayden AR; Tonseth P; Lee DG; Villa D; Gerrie AS; Scott DW; Freeman CL; Slack GW; Farinha P; Skinnider B; Yenson PR; Benard F; Lo A; Pickles T; Wilson D; Connors JM; Sehn LH; Savage KJ
Blood; 2020 Dec; 136(24):2803-2811. PubMed ID: 32603413
[TBL] [Abstract][Full Text] [Related]
4. Primary mediastinal large B-cell lymphoma.
Martelli M; Ferreri A; Di Rocco A; Ansuinelli M; Johnson PWM
Crit Rev Oncol Hematol; 2017 May; 113():318-327. PubMed ID: 28318892
[TBL] [Abstract][Full Text] [Related]
5. End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making.
Melani C; Advani R; Roschewski M; Walters KM; Chen CC; Baratto L; Ahlman MA; Miljkovic MD; Steinberg SM; Lam J; Shovlin M; Dunleavy K; Pittaluga S; Jaffe ES; Wilson WH
Haematologica; 2018 Aug; 103(8):1337-1344. PubMed ID: 29748435
[TBL] [Abstract][Full Text] [Related]
6. Primary mediastinal lymphoma: diagnosis and treatment options.
Martelli M; Di Rocco A; Russo E; Perrone S; Foà R
Expert Rev Hematol; 2015 Apr; 8(2):173-86. PubMed ID: 25537750
[TBL] [Abstract][Full Text] [Related]
7. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma.
Yang SH; Hsiao LT; Chiou TJ; Yang CF; Yu YB; Liu CY; Gau JP; Liu JH; Chen PM; Tzeng CH
J Chin Med Assoc; 2015 Jul; 78(7):400-7. PubMed ID: 25801492
[TBL] [Abstract][Full Text] [Related]
8. [Large-cell mediastinal lymphoma].
Gori E; Tata F; Zanna M; Bruzzone G
Clin Ter; 1991 Oct 15-31; 139(1-2):45-8. PubMed ID: 1837766
[TBL] [Abstract][Full Text] [Related]
9. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
[TBL] [Abstract][Full Text] [Related]
10. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial to assess the efficacy of radiotherapy in primary mediastinal large B-lymphoma.
Avilés A; Neri N; Fernández R; Huerta-Guzmán J; Nambo MJ
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1227-31. PubMed ID: 22172907
[TBL] [Abstract][Full Text] [Related]
12. End of treatment FDG-PET in primary mediastinal B-cell lymphoma treated with R-chemotherapy: Prognostic indicator and implications for consolidation radiotherapy.
Freitas AC; Carvalho IP; Esteves S; Salgado L; Gomes da Silva M
Eur J Haematol; 2022 Feb; 108(2):118-124. PubMed ID: 34599779
[TBL] [Abstract][Full Text] [Related]
13. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
Papageorgiou SG; Diamantopoulos P; Levidou G; Angelopoulou MK; Economopoulou P; Efthimiou A; Constantinou N; Katsigiannis A; Korkolopoulou P; Pappa V; Economopoulou C; Georgiou G; Dimou M; Tsirigotis P; Kyrtsonis MC; Kotsianidis I; Kalpadakis C; Dimopoulos MA; Beris P; Meletis J; Pangalis GA; Dervenoulas J; Panayiotidis P; Vassilakopoulos TP
Hematol Oncol; 2013 Mar; 31(1):10-7. PubMed ID: 22610484
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
Zinzani PL; Martelli M; Bertini M; Gianni AM; Devizzi L; Federico M; Pangalis G; Michels J; Zucca E; Cantonetti M; Cortelazzo S; Wotherspoon A; Ferreri AJ; Zaja F; Lauria F; De Renzo A; Liberati MA; Falini B; Balzarotti M; Calderoni A; Zaccaria A; Gentilini P; Fattori PP; Pavone E; Angelopoulou MK; Alinari L; Brugiatelli M; Di Renzo N; Bonifazi F; Pileri SA; Cavalli F;
Haematologica; 2002 Dec; 87(12):1258-64. PubMed ID: 12495899
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.
Xu LM; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Liu QF; Chen B; Qi SN; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1289-95. PubMed ID: 23245279
[TBL] [Abstract][Full Text] [Related]
16. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Zinzani PL; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S
Haematologica; 2001 Feb; 86(2):187-91. PubMed ID: 11224489
[TBL] [Abstract][Full Text] [Related]
17. Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Récher C; Coiffier B; Haioun C; Molina TJ; Fermé C; Casasnovas O; Thiéblemont C; Bosly A; Laurent G; Morschhauser F; Ghesquières H; Jardin F; Bologna S; Fruchart C; Corront B; Gabarre J; Bonnet C; Janvier M; Canioni D; Jais JP; Salles G; Tilly H;
Lancet; 2011 Nov; 378(9806):1858-67. PubMed ID: 22118442
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
19. [The primary mediastinal lymphoma: state of the art and therapeutical perspectives].
Foppoli M; Citterio G; Donadoni G; Govi S; Ferreri AJ
Recenti Prog Med; 2013 May; 104(5):203-8. PubMed ID: 23748685
[TBL] [Abstract][Full Text] [Related]
20. Advances in the management of primary mediastinal large B-cell lymphoma.
Advani RH
Clin Adv Hematol Oncol; 2018 Jan; 16(1):33-34. PubMed ID: 29741502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
